期刊文献+

血浆同型半胱氨酸水平与原发性高血压冠心病的相关性 被引量:14

Relationship between Plasma Homocysteine Level and Occurrence of Coronary Heart Disease in Patients with Essential Hypertension
下载PDF
导出
摘要 目的:探讨血浆同型半胱氨酸(Hcy)水平对原发性高血压患者发生冠心病的预测价值。方法:原发性高血压患者251例,根据冠脉造影结果分为单纯性高血压组(A组)和高血压合并冠心病组(B组),检测2组患者血浆Hcy、血糖、总胆固醇、甘油三酯、低密度脂蛋白、高密度脂蛋白、血尿酸、肌酐以及尿素氮水平,比较不同Hcy水平患者冠心病的发病率,通过logistic回归分析原发性高血压患者发生冠心病的危险因素。结果:A组患者血浆Hcy水平和低密度脂蛋白水平低于B组患者,而高密度脂蛋白水平高于B组患者,差异有统计学意义(P<0.05);血浆同型半胱氨酸水平(OR=4.503,P<0.05)和低密度脂蛋白水平(OR=3.509,P<0.05)是原发性高血压发生冠心病的独立危险因素;高密度脂蛋白可以降低原发性高血压患者发生冠心病的风险(OR=0.439,P<0.05)。结论:血浆同型半胱氨酸水平升高的患者发生冠心病的可能性大。 Objective: To explore the value of homocysteine (Hcy) levels in predicting the occur- rence of coronary heart disease (CHD) in patients with essential hypertension. Methods: Based on the results of coronary angiography, 251 patients with essential hypertension were divided into two groups as essential hypertension group (group A) and essential hypertension with CHD group (group B). Levels of Hey, blood glucose, serum total cholesterol, triglyceride, low density lipoprotein, high density lipoprotein, blood uric acid, creatinine, urea nitrogen were detected, and the incidences of CHD in essential hypertension patients with different Hcy levels were compared. The logistic regression model was used to analyze the risk factors for occurrence of CHD. Results: The levels of Hey and low density lipoprotein in group B were higher than those in group A, while high density lipoprotein level was lower than that in group A (P 〈 0.05 ). The levels of Hcy ( OR = 4. 503, P 〈 0.05 ) and low density lipoprotein( OR =3.509,P 〈0.05)were independent predictors of CHD in patients with essential hy- pertension, while high density lipoprotein can decrease the incidence of CHD in patients with essential hypertension (OR = 0. 439, P 〈 0.05 ). Conclusion: CHD is more likely to occur in essential hyperten- sion patients with high Hey levels
作者 杨湛南
出处 《贵阳医学院学报》 CAS 2015年第1期97-99,103,共4页 Journal of Guiyang Medical College
关键词 高血压 冠心病 同型半胱氨酸 预测 血浆 hypertension coronary heart disease homocysteine prognosis plasma
  • 相关文献

参考文献12

  • 1Go AS,Mozaffarian D,Roger VL,et al.Executive summary:heart disease and stroke statistics:2013 update:a report from the American heart association[J].Circulation,2013(1):143-146. 被引量:1
  • 2Roger VL,Go AS,Lloyd-Jones DM,et al.Heart disease and stroke statistics-2011 update a report from the American heart association[J].Circulation,2011(4):18-19. 被引量:1
  • 3Goldstein LB,Bushnell CD,Adams RJ,et al.Guidelines for the primary prevention of stroke a guideline for health care professionals from the American heart association/American stroke association[J].Stroke,2011(2):517-584. 被引量:1
  • 4Clarke R,Halsey J,Bennett D,et al.Homocysteine and vascular disease:review of published results of the homocysteine-lowering trials[J].Journal of Inherited Metabolic Disease,2011(1):83-91. 被引量:1
  • 5Sydow K,Bger RH.Reloaded:ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inaemia:effects of l-arginine and B vitamins[J].Cardiovascular Research,2012(2):167-171. 被引量:1
  • 6Kloppenborg RP,Nederkoorn PJ,vander GY,et al.Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease.The Smart-MR study[J].Atherosclerosis,2011(2):461-466. 被引量:1
  • 7Tehlivets O.Homocysteine as a risk factor for atherosclerosis:is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism?[J].Journal of Lipids,2011(10):1-11. 被引量:1
  • 8Pera-Kaján J,Twardowski T,Jakubowski H.Mechanisms of homocysteine toxicity in humans[J].Amino acids,2007(4):561-572. 被引量:1
  • 9Smith DE,Smulders YM,Blom HJ,et al.Determinants of the essential one-carbon metabolism metabolites,homocysteine,S-adenosylmethionine,S-adenosylhomocysteine and folate,in cerebrospinal fluid[J].Clin Chem Lab Med,2012(9):1641-1647. 被引量:1
  • 10王淑敏,王艳丽,张凌云.血清同型半胱氨酸水平对复发脑梗死的预测价值[J].中日友好医院学报,2010,24(4):218-219. 被引量:10

二级参考文献27

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33055
  • 2谈晓牧,刘建国,刘怀翔,高海风,张哲成.高同型半胱氨酸血症与脑梗死复发率关系的随访研究[J].中华神经科杂志,2006,39(9):591-594. 被引量:51
  • 3Bradbrry JC,Fagan SC,Gray DR,et al.New perspectives on the pharmacotherapy of ischemic stroke[J].J Am Pharm Assoc,2004,44(2 Suppl):S46-56. 被引量:1
  • 4Ruland S,Richardson D,Hung E,et al.Predictors of recurrent stroke in African Americans[J].Neurology,2006,67(4):567-571. 被引量:1
  • 5Boushey CJ,Beresford SA,Omenn GS,et al.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease[J].JAMA,1995,274(13):1049-1057. 被引量:1
  • 6Dhamij RK,Gaba P,Arora S.Homocysteine and lipoprotein(a)correlation in ischemic stroke patients[J].Journal of the Neurological Sciences,2009,281:64-68. 被引量:1
  • 7Boysen G,Brander T,Christensen H,et al.Homocysteine and risk of recurrent stroke[J].Stroke,2003,34(5):1258-1261. 被引量:1
  • 8Sen S,Hinderliter A,Sen PK,et al.Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack[J].Circulation,2007,116(8):928-935. 被引量:1
  • 9Cui RZ,Moriyam YR,Koike KA.Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese:The JACC study[J].Atherosclerosis,2008,198:412-418. 被引量:1
  • 10袁国祥,龚自强.腔隙性脑梗塞发病因素分析[J].临床神经病学杂志,1997,10(1):60-60. 被引量:23

共引文献25

同被引文献111

引证文献14

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部